Default object view. Click to create a custom template, Node ID: 169131, Object ID: 101414

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

No relation

Yes

No relation

No

29/08/2016 2:56 pm

No